The coming storm in the pharma supply chain

Keith Bontrager was a pioneer in mountain bike design who famously spoke of a ‘value triangle’ when it came to bikes. “Strong, light, cheap...
Syringe with liquid to show new opportunities to increase adult vaccination rates

Pharmacy’s role in vaccinations: Protecting the nation’s health

What is the pharmacy’s role in vaccinations? Flu is a major cause of harm to individuals, leading to around 16,000 attributable deaths last season (over...
Robot holding first aid kit AI in pharma

How AI is making its way into pharma and healthcare

Will we see enhancements of AI in pharma and healthcare? Having read many insightful articles and spoken to several experts on how artificial intelligence (AI)...
painter removing star from EU flag highlighting how pharma can prepare for Brexit

Brexit and the UK life science industry

Damon Culbert looks at Brexit and the UK life science industry with particular consideration to the impact of immigration. For many industry professionals, Britain’s plans to leave the European...
Lady of justice showing High Court ruling against Novartis and Bayer

High Court ruling against Novartis and Bayer: Implications

Claudia Rubin and Tom Jaggs explore the implications of the High Court ruling against Novartis and Bayer for pharma. High Court ruling against Novartis and...

NHS long-term plan: Growing importance of prevention medicine

“The challenge now is for the NHS to respond to this changing landscape and to focus on preventing as well as treating the conditions...
Nuformix apprval to start NXP001 human pharmacokinetics studies

Have analytics been relegated to a reporting function?

Have business analytics been pushed to the background? Business information upgraded, smart CRM datasets, the Predictive Analytics silver bullet and other fairy tales.

Is Brexit good news for pharma?

James Burt, Executive Vice President EMENA, Accord Healthcare, asks whether Brexit will in fact present an opportunity for positive change in pharma and healthcare.
painter removing star from EU flag highlighting how pharma can prepare for Brexit

What do NHS changes mean for tech innovation?

Could changes at the top mean fresh opportunities for tech innovation? Read this in the August issue of Pf Magazine.  For some time it has been...

At the heart of it: The vital role of pharmacies in community health

Read this in the August issue of Pf Magazine.  Community pharmacy has a clear role in promoting and supporting the public’s health. There’s an accessible...

Latest articles

Dr Harry Destecroix of Ziylo wins 2019 Pharmaceutical Industry Network Group Innovation Award

Biotech leader wins PING Innovation Award 2019

Dr Harry Destecroix of Ziylo has won the 2019 Pharmaceutical Industry Network Group (PING) Innovation Award, hosted by pharma and life sciences specialist law...
NICE recommend funding for Spinraza

NICE recommend funding for Spinraza for spinal muscular atrophy

The National Institute for Health and Care Excellence (NICE) has recommended funding for Spinraza (nusinersen) on the National Health Service (NHS). The positive recommendation, subject to...
Data from Symbicort Turbuhaler Novel START trial among 73 AstraZeneca abstracts accepted for presentation at ATS

New data from Novel START trial accepted for presentation

New data from the Symbicort Turbuhaler (budesonide/formoterol) Novel START trial is among 73 AstraZeneca abstracts accepted for oral or poster presentation at the American...

Popular articles

pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
new migraine data for Aimovig presented by Novartis

Novartis presents new migraine data for Aimovig®▼ (erenumab)

Novartis presents new migraine data for Aimovig®▼ (erenumab) demonstrating sustained efficacy to 52 weeks. Novartis has announced that new data from two follow-up studies of...
Data from Symbicort Turbuhaler Novel START trial among 73 AstraZeneca abstracts accepted for presentation at ATS

New data from Novel START trial accepted for presentation

New data from the Symbicort Turbuhaler (budesonide/formoterol) Novel START trial is among 73 AstraZeneca abstracts accepted for oral or poster presentation at the American...

Top 5 R&D hubs in the UK

Read this cover story in the June issue of Pf Magazine here.    Join us on a tour of inspirational research and development centres. ...
Dr Harry Destecroix of Ziylo wins 2019 Pharmaceutical Industry Network Group Innovation Award

Biotech leader wins PING Innovation Award 2019

Dr Harry Destecroix of Ziylo has won the 2019 Pharmaceutical Industry Network Group (PING) Innovation Award, hosted by pharma and life sciences specialist law...